Prasad Parmeshwaran joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

Press releases

July 20, 2022

NEW YORK, July 20, 2022 – Lazard Ltd (NYSE: LAZ) announced today that Prasad Parmeshwaran has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in San Francisco, Mr. Parmeshwaran primarily advises clients on financial matters in the biotechnology and diagnostics sectors.

“We welcome Prasad, who brings nearly two decades of advising healthcare clients, particularly
in biotechnology and diagnostics M&A,” said David Gluckman, Global Head of the Healthcare
Group at Lazard. “He joins our well-established team on the West Coast, bolstering our presence
advising on private and public strategic transactions.”

Prior to joining Lazard, Mr. Parmeshwaran was a Managing Director at Cowen Inc. where he built
and oversaw the firm’s Healthcare M&A group since 2016. Earlier in his career he held investment
banking roles in the healthcare group at Goldman Sachs, where he worked for 10 years. Mr.
Parmeshwaran obtained his postgraduate diploma in management from the Indian Institute of
Management, and his M.B.A. from the New York University Stern School of Business.

About Lazard

Founded in 1848, Lazard is one of the world's preeminent financial advisory and asset management firms, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit


Judi Frost Mackey

+1 212 632 1428